Ad
CTMX Short Information CytomX Therapeutics Inc.
home / stock / ctmx / ctmx short
Short Information | CytomX Therapeutics Inc. (NASDAQ:CTMX)
| Twenty Trading Day Totals | |
|---|---|
| Total Shorted Volume | 13,804,833 |
| Total Actual Volume | 60,169,882 |
| Short Trends | |
|---|---|
| Cover Days | 18 |
| Short Days | 0 |
| No Change Days | 2 |
| Averages | |
|---|---|
| Average Short Volume | 690,242 |
| Average Short Percentage | 23.53% |
Is there a CTMX Short Squeeze or Breakout about to happen?
See the CTMX Short Analysis for free Sign up or Login
Powered by Squeeze Report
CTMX Twenty Trading Day's Volume to Short Volume Chart
CTMX Twenty Trading Day Price Chart
CTMX Short Data Results Days
| Date | Open | Close | High | Low | Total Volume | Short Volume | Short Percentage |
|---|---|---|---|---|---|---|---|
| 06-18-2025 | $2.39 | $2.11 | $2.39 | $2.075 | 4,132,785 | 889,583 | 21.53% |
| 06-17-2025 | $2.48 | $2.38 | $2.53 | $2.33 | 2,039,977 | 508,893 | 24.95% |
| 06-16-2025 | $2.83 | $2.46 | $2.87 | $2.46 | 2,840,134 | 781,289 | 27.51% |
| 06-13-2025 | $2.95 | $2.75 | $3.095 | $2.71 | 1,974,648 | 511,101 | 25.88% |
| 06-12-2025 | $2.8 | $2.99 | $3 | $2.75 | 1,796,133 | 351,306 | 19.56% |
| 06-11-2025 | $2.73 | $2.82 | $2.885 | $2.66 | 2,111,365 | 463,104 | 21.93% |
| 06-10-2025 | $2.63 | $2.7 | $2.825 | $2.57 | 2,553,097 | 939,966 | 36.82% |
| 06-09-2025 | $2.66 | $2.635 | $2.875 | $2.63 | 4,284,712 | 1,293,757 | 30.19% |
| 06-06-2025 | $2.46 | $2.64 | $2.707 | $2.4301 | 3,414,356 | 608,833 | 17.83% |
| 06-05-2025 | $2.47 | $2.4 | $2.58 | $2.35 | 2,208,734 | 492,338 | 22.29% |
| 06-04-2025 | $2.65 | $2.51 | $2.75 | $2.51 | 2,118,141 | 849,769 | 40.12% |
| 06-03-2025 | $2.5 | $2.65 | $2.67 | $2.46 | 1,515,524 | 330,336 | 21.8% |
| 06-02-2025 | $2.63 | $2.51 | $2.82 | $2.45 | 3,125,188 | 535,196 | 17.13% |
| 05-30-2025 | $2.53 | $2.65 | $2.71 | $2.45 | 3,905,734 | 748,984 | 19.18% |
| 05-29-2025 | $2.4 | $2.52 | $2.585 | $2.38 | 3,554,556 | 574,655 | 16.17% |
| 05-28-2025 | $2.13 | $2.4 | $2.64 | $2.12 | 5,243,677 | 1,010,925 | 19.28% |
| 05-27-2025 | $2.27 | $2.125 | $2.2981 | $2.1 | 3,738,101 | 538,267 | 14.4% |
| 05-23-2025 | $2.06 | $2.23 | $2.29 | $2.03 | 3,095,268 | 731,517 | 23.63% |
| 05-22-2025 | $2.02 | $2.13 | $2.23 | $2.005 | 3,719,603 | 953,250 | 25.63% |
| 05-21-2025 | $2 | $2.04 | $2.11 | $1.98 | 2,798,149 | 691,764 | 24.72% |
News, Short Squeeze, Breakout and More Instantly...
CytomX Therapeutics Inc. Company Name:
CTMX Stock Symbol:
NASDAQ Market:
0.0% G/L:
$2.11 Last:
4,132,785 Volume:
$2.39 Open:
$2.11 Close:
CytomX Therapeutics Inc. Website:
Ad
-
SOUTH SAN FRANCISCO, Calif., May 19, 2025 (GLOBE NEWSWIRE) -- CytomX Therapeutics, Inc. (Nasdaq: CTMX), a leader in the field of masked, conditionally activated biologics, today announced that the first patient has been dosed with CX-801 in combination with KEYTRUDA ® (pembrolizumab), Me...
-
2025-05-12 10:14:56 ET DENVER, Colo., May 12, 2025 ( 247marketnews.com )- The markets are full of stocks running on tariff, crypto, and other developments. Gryphon Digital Mining (NASDAQ:GRYP) entered into a definitive merger agreement with American Bitcoin, which is focused on buil...
-
- Announced Positive Interim Data From Ongoing Phase 1 Dose Escalation Study of EpCAM Antibody Drug Conjugate (CX-2051) in Patients with Advanced Colorectal Cancer (CRC) - - Initiated CX-2051 Phase 1 dose expansions at 7.2 mg/kg, 8.6 mg/kg, and 10 mg/kg doses. Additional CX-2051 Phase 1 d...